|
1
|
Mohammadi M and Hedayati M: A brief review
on the molecular basis of medullary thyroid carcinoma. Cell J.
18:485–492. 2017.PubMed/NCBI
|
|
2
|
Bae YJ, Schaab M and Kratzsch J:
Calcitonin as biomarker for the medullary thyroid carcinoma. Recent
Results Cancer Res. 204:117–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hazard JB, Hawk WA and Crile G Jr:
Medullary (solid) carcinoma of the thyroid; a clinicopathologic
entity. J Clin Endocrinol Metab. 19:152–161. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elisei R, Alevizaki M, Conte-Devolx B,
Frank-Raue K, Leite V and Williams GR: 2012 European thyroid
association guidelines for genetic testing and its clinical
consequences in medullary thyroid cancer. Eur Thyroid J. 1:216–231.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roman S, Lin R and Sosa JA: Prognosis of
medullary thyroid carcinoma: Demographic, clinical, and pathologic
predictors ofsurvival in 1252 cases. Cancer. 107:2134–2142. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in Europe: Estimates for 40
countries and 25 major cancers in 2018. Eur J Cancer. 103:356–387.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kebebew E, Ituarte PH, Siperstein AE, Duh
QY and Clark OH: Medullary thyroid carcinoma: Clinical
characteristics, treatment, prognostic factors, and a comparison of
staging systems. Cancer. 88:1139–1148. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grande E, Santamaría Sandi J, Capdevila J,
Navarro González E, Zafón Llopis C, Ramón Y Cajal Asensio T, Gómez
Sáez JM, Jiménez-Fonseca P, Riesco-Eizaguirre G and Galofré JC:
Consensus on management of advanced medullary thyroid carcinoma on
behalf of the working group of thyroid cancer of the Spanish
society of endocrinology (SEEN) and the Spanish task force group
for orphan and infrequent tumors (GETHI). Clin Transl Oncol.
18:769–775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang GC, Fried K and Levine PH: Detection
of medullary thyroid microcarcinoma using ultrasound-guided fine
needle aspiration cytology. Cytopathology. 24:92–98. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Essig GF Jr, Porter K, Schneider D, Debora
A, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit
JW, et al: Fine needle aspiration and medullary thyroid carcinoma:
The risk of inadequate preoperative evaluation and initial surgery
when relying upon FNAB cytology alone. Endocr Pract. 19:920–927.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trimboli P, Treglia G, Guidobaldi L,
Romanelli F, Nigri G, Valabrega S, Sadeghi R, Crescenzi A, Faquin
WC, Bongiovanni M and Giovanella L: Detection rate of FNA cytology
in medullary thyroid carcinoma: A meta-analysis. Clin Endocrinol
(Oxf). 82:280–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jung KY, Kim SM, Yoo WS, Kim BW, Lee YS,
Kim KW, Lee KE, Jeong JJ, Nam KH, Lee SH, et al: Postoperative
biochemical remission of serum calcitonin is the best predictive
factor for recurrence-free survival of medullary thyroid cancer: A
large-scale retrospective analysis over 30 years. Clin Endocrinol
(Oxf). 84:587–597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raue F and Frank-Raue K: Long-term
follow-up in medullary thyroid carcinoma. Recent Results Cancer
Res. 204:207–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wells SA Jr, Asa SL, Dralle H, Elisei R,
Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, et al:
Revised American Thyroid Association guidelines for the management
of medullary thyroid carcinoma. Thyroid. 25:567–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Romei C, Ciampi R and Elisei R: A
comprehensive overview of the role of the RET proto-oncogene in
thyroid carcinoma. Nat Rev Endocrinol. 12:192–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee S, Shin JH, Han BK and Ko EY:
Medullary thyroid carcinoma: Comparison with papillary thyroid
carcinoma and application of current sonographic criteria. AJR Am J
Roentgenol. 194:1090–1094. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SH, Kim BS, Jung SL, Lee JW, Yang PS,
Kang BJ, Lim HW, Kim JY, Whang IY, Kwon HS and Jung CK:
Ultrasonographic findings of medullary thyroid carcinoma: A
comparison with papillary thyroid carcinoma. Korean J Radiol.
10:101–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trimboli P, Giovanella L, Valabrega S,
Andrioli M, Baldelli R, Cremonini N, Rossi F, Guidobaldi L,
Barnabei A, Rota F, et al: Ultrasound features of medullary thyroid
carcinoma correlate with cancer aggressiveness: A retrospective
multicenter study. J Exp Clin Cancer Res. 33:872014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi N, Moon WJ, Lee JH, Baek JH, Kim DW
and Park SW: Ultrasonographic findings of medullary thyroid cancer:
Differences according to tumor size andcorrelation with fine needle
aspiration results. Acta Radiol. 52:312–316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ganeshan D, Paulson E, Duran C, Cabanillas
ME, Busaidy NL and Charnsangavej C: Current update on medullary
thyroid carcinoma. AJR Am J Roentgenol. 201:W867–W876. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho KE, Gweon HM, Park AY, Yoo MR, Kim J,
Youk JH, Park YM and Son EJ: Ultrasonographic features of medullary
thyroid carcinoma: Do they correlate with Pre and PostOperative
calcitonin levels? Asian Pac J Cancer Prev. 17:3357–3362.
2016.PubMed/NCBI
|
|
22
|
Woliński K, Rewaj-Łosyk M and Ruchała M:
Sonographic features of medullary thyroid carcinomas-a systematic
review and meta-analysis. Endokrynol Pol. 65:314–318. 2014.
View Article : Google Scholar
|
|
23
|
Costante G, Meringolo D, Durante C,
Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M,
Torlontano M and Filetti S: Predictive value of serum calcitonin
levels for preoperative diagnosis of medullary thyroid carcinoma in
a cohort of 5817 consecutive patients with thyroid nodules. J Clin
Endocrinol Metab. 92:450–455. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chambon G, Alovisetti C, Idoux-Louche C,
Reynaud C, Rodier M, Guedj AM, Chapuis H, Lallemant JG and
Lallemant B: The use of preoperative routine measurement of basal
serum thyrocalcitonin in candidates for thyroidectomy due to
nodular thyroid disorders: Results from 2733 consecutive patients.
J Clin Endocrinol Metab. 96:75–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elisei R, Bottici V, Luchetti F, Di Coscio
G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A
and Pacini F: Impact of routine measurement of serum calcitonin on
the diagnosis and outcome of medullary thyroid cancer: Experience
in 10,864 patients with nodular thyroid disorders. J Clin
Endocrinol Metab. 89:163–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Papapetrou PD and Polymeris A: Medullary
thyroid carcinoma surgical cytoreduction induces an increase in
serum calcitonin and carcinoembryonic antigen doubling times. Exp
Clin Endocrinol Diabetes. 120:164–168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boschin IM, Torresan F, Toniato A, Zane M,
Ide EC, Pennelli G, Rampin L, Colletti PM, Rubello D and Pelizzo
MR: Incidental medullary thyroid microcarcinoma revealed by mild
increase of preoperative serum calcitonin levels: Therapeutic
implications. Endocrine. 45:448–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Machens A, Hauptmann S and Dralle H:
Prediction of lateral lymph node metastases in medullary thyroid
cancer. Br J Surg. 95:586–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rowland KJ, Jin LX and Moley JF:
Biochemical cure after reoperations for medullary thyroid
carcinoma: A meta-analysis. Ann Surg Oncol. 22:96–102. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosario PW and Calsolari MR: Usefulness of
serum calcitonin in patients without a suspicious history of
medullary thyroid carcinoma and with thyroid nodules without an
indication for fine-needle aspiration or with benign cytology. Horm
Metab Res. 48:372–276. 2016. View Article : Google Scholar : PubMed/NCBI
|
